Know Cancer

or
forgot password
  • cancer clinical trials in chicago, IL

  • Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    Swedish Covenant Hospital
    Hematology and Oncology Associates
    Northwestern University
    Mount Sinai Hospital Medical Center
    University of Chicago Comprehensive Cancer Center
    Resurrection Healthcare
    University of Illinois
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Ovarian Cancer
    Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
    University of Illinois Cancer Center

    Trial Locations
    University of Illinois Cancer Center
    Veterans Affairs Medical Center - Chicago Westside Hospital
    Creticos Cancer Center at Advocate Illinois Masonic Medical Center
    Lung Cancer
    Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Rush Cancer Institute at Rush University Medical Center
    Leukemia
    Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
    Celldex Investigational Site
    Chicago, Illinois 60611
    Malignant Glioma
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    University of Illinois Cancer Center
    Chicago, Illinois 60612-7243
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Phase 1 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
    University of Chicago, School of Medicine
    Chicago, Illinois 60637
    Multiple Myeloma
    Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
    Cancer Center of Northwestern University
    Chicago, Illinois 60611
    Leukemia, Hairy Cell Leukemia, HCL
    VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Northwestern University

    Trial Locations
    Northwestern University
    University of Chicago Comprehensive Cancer Center
    University of Illinois
    Recurrent Endometrial Carcinoma
    Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Lymphoma
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Children's Memorial Hospital - Chicago

    Trial Locations
    Children's Memorial Hospital - Chicago
    University of Illinois Cancer Center
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
    Northwestern University School of Medicine, Stem Cell Transplant Program, Children's Memorial Hospital
    Chicago, Illinois 60614
    Hematologic Malignancies, Acute Myeloid Leukemia, Lymphoid Leukemia, Chronic Myeloid Leukemia, Hodgkin's Disease, Non-Hodgkin's Lymphoma, Myelodysplastic Syndromes
    Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    MBCCOP - University of Illinois at Chicago
    Chicago, Illinois 60612
    Neurotoxicity, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
    University of Chicago Medical Center Section of Hematology/Oncology
    Chicago, Illinois 60546
    Myelogenous Leukemia, Chronic
    Sunitinib in Treating Patients With Recurrent or Metastatic Endometrial Cancer
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    Endometrial Adenocarcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Uterine Sarcoma, Stage IV Endometrial Carcinoma, Stage IV Uterine Sarcoma, Uterine Carcinosarcoma
    Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
    Northwestern University
    Chicago, Illinois 60611
    Healthy, no Evidence of Disease
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    John H. Stroger, Jr. Hospital of Cook County
    Resurrection Medical Center
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    Endometrial Cancer
    S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Hematology and Oncology Associates
    Leukemia
    Adj TC + Herceptin Early Stage Breast Cancer
    Hematology Oncology Associates of IL
    Chicago, Illinois 60611
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Hematology Oncology Associates of IL
    Chicago, Illinois 60611
    Breast Cancer
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    University of Chicago Cancer Research Center
    Chicago, Illinois 60637
    Lung Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    John H Stroger Jr Hospital of Cook County

    Trial Locations
    John H Stroger Jr Hospital of Cook County
    Resurrection Healthcare
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Children's Memorial Hospital - Chicago
    University of Illinois Cancer Center
    Neuroblastoma
    Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Oropharyngeal Function After Radiotherapy With IMRT
    Northwestern University
    Chicago, Illinois 60611
    Head and Neck Neoplasms
    Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone
    John H. Stroger, Jr. Hospital of Cook County

    Trial Locations
    John H. Stroger, Jr. Hospital of Cook County
    University of Chicago
    Multiple Myeloma
    Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
    Northwestern Universtiy
    Chicago, Illinois 60611
    Multiple Myeloma
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Resurrection Healthcare
    Chicago, Illinois 60631
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer